Cite
HARVARD Citation
Vaglica, M. et al. (n.d.). A12First line trastuzumab- or lapatinib-based therapy in her2-positive metastatic breast cancer patients after prior (NEO)adjuvant trastuzumab. Annals of oncology. pp. vi6-vi7. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Vaglica, M. et al. (n.d.). A12First line trastuzumab- or lapatinib-based therapy in her2-positive metastatic breast cancer patients after prior (NEO)adjuvant trastuzumab. Annals of oncology. pp. vi6-vi7. [Online].